Delivery Order SPE2DR25D1205-SPE2DR26F0ZN1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 29, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of January 21, 2026. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Benlysta 200 mg/ml auto-injectors. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a non-competitive set-aside award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of January 22, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 2, 2026, with a completion date of January 26, 2026. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of January 28, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and was executed on January 6, 2026. The awardee will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, issued with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure with an ultimate completion date of October 14, 2025. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for Benlysta 200 mg/mL auto-injector pharmaceutical products. The order is a firm fixed price, non-set-aside contract with a completion date of December 30, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete procurement action under a larger contracting vehicle that enables AmerisourceBergen to supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,082.67 delivery order contract to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. The contract, which is not set-aside and operates under firm fixed pricing, is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0ZN1Delivery Order
The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication. This competitively awarded, firm fixed-price contract has an ultimate completion date of January 30, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. No small business set-aside was applied to this contract award. AmerisourceBergen Drug Corp, operating as a division of Cencora, Inc., is a major pharmaceutical distributor providing critical medical products to federal agencies, particularly military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to efficiently fulfill government requirements for pharmaceutical commodities across multiple therapeutic domains, from specialty medications to vaccines and medical devices, supporting military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 1/7/26 |